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1. Introduction      
One of the major challenges to delivering effective health care to patients with complex, 
chronic health problems is that health systems have been designed to deal with acute 
episodic illness. This has lead to increasing specialization in treatment of disease, focused on 
individual body systems and indeed one part of one organ. When a person becomes acutely 
ill and requires expertise that cannot be managed by a primary care physician they are 
referred for specialized care. As the population ages we are seeing more chronic health 
conditions which require long term management, often punctuated by episodes requiring 
acute care. As the burden of chronic disease has increased it has been recognized that 
management becomes more complex when there are interacting problems like hypertension, 
cardiac disease and diabetes. Individual “diseases” are more easily managed, but when 
there are multiple diagnoses, management becomes more difficult. Fortunately many of 
these chronic conditions have clear guidelines for monitoring and treatment, and even 
where there can be several problems in the same patient the guidelines are followed. 
However, patients who develop more difficult problems in more than one body system 
often end up with treatment from multiple specialists. Coordination of the efforts of the 
various specialists usually rests in the hands of primary care physicians, which presents 
many challenges (Henningsen et al 2003, Verhaak et al. 2006). In Canada, family physicians 
provide primary care and for the most part work independently, not within a team of other 
health professionals. Most family physicians have a heavy workload and usually see many 
patients during fairly short visits. Patients with multiple, interacting problems present a 
major challenge for family physicians(Fink & Rosendal 2008). When someone is chronically 
ill with multiple conditions, they often see different clinicians at different sites. This 
increases the risks of errors and of poor care coordination. Undoubtedly this increases 
suffering for the individual and higher health care costs for society. These issues have been 
recognized in the elderly population and the speciality of geriatrics has developed which 
specializes in the management of the frail elderly (Rockwood et al 1994). Frailty is more 
likely with more health problems or deficits (Rockwood et al 2004), and the most frail 





No such specialization has developed in dealing with younger patients with multiple 
interacting problems and it is much more difficult for primary care physicians to manage  
poorly understood chronic illnesses. Often these chronic illnesses are not recognized as 
specific illnesses or diseases, but only as chronic problems with medically unexplained 
symptoms. These kinds of problems present major challenges and we know that they are 
common in Western populations. Chronic fatigue syndrome is known to affect between 
400,000 and 900,000 adults in the United States (Jason et al 1999, Reyes et al 2003). About 
16% of Californians report that they are unusually sensitive to chemicals and 6.3% have 
been diagnosed with environmental illness (Kreutzer et al 1999). Hypersensitivy to 
chemicals leading to illness has also been reported to affect about 13% of a population in 
Georgia, United States (Caress and Steinemann 2004). Chronic illnesses, which are not well 
understood are common problems which place a significant burden on health care systems. 
There are several, major challenges to effective care. It takes longer to make a diagnosis 
(Stockl 2007), to identify solutions and offer recommendations for the multiple problems. 
Another issue is being able to offer treatment recommendations which are evidence based 
and in accordance with published guidelines. This is impossible if the patient seeking help 
has medically unexplained symptoms, or is diagnosed with a condition such as multiple 
chemical sensitivity, chronic fatigue syndrome or fibromyalgia, since widely accepted 
guidelines do not exist. So what kind of care can be provided when the physician is faced 
with a patient who is experiencing life-changing ill health and who reports extensive 
suffering and disability? The physician may well ponder various questions such as “Which 
specialist is able to help?” or “What can I offer for treatment?” or “Where can I find the time 
to listen to the various complaints?”  
In one prospective study of 300 new patients referred to a neurology clinic, 11% had 
symptoms which were not at all explained by organic disease and a further 19% were only 
somewhat explained (Carson et al 2000). The authors concluded that these patients were 
disabled, distressed and deserved more attention. Being unable to fully understand the 
disease process or to make a specific diagnoses should not prevent provision of appropriate 
health care. Indeed there are reports of various approaches to help individuals and alleviate 
suffering, for example by offering cognitive behavioral therapy (Martin et al 2007). 
Sumathipala (2007) reviewed published literature for the highest level of evidence on the 
efficacy of treatment for patients with medically unexplained symptoms, and concluded 
that there was more evidence for cognitive behavioural therapy improving the health of 
these patients than for any other form of therapy. 
The term medically unexplained symptoms was probably first used by de Figueiredo (1980) 
when describing a case of Briquet’s syndrome, a recognized psychiatric disease. Since that 
introduction, the term has been used to describe any condition that lacks structural 
pathology in the tissues (Nettleton 2006; Binder 2004; Smythe 2005). It is obvious from the  
literature on medically unexplained symptoms, that many authors have a psychological or 
psychiatric background, and therefore interpret the illness as being secondary to 
psychopathology. There is little discussion of the biological aspects of the illnesses 
diagnosed in patients with unexplained medical symptoms. Another label that is applied to 
these difficult and complex patients is somatization disorder, or that the symptoms are 
manifestations of somatization. To identify the illness as somatization disorder is not 
appropriate for this patient population with chronic ill health. To make such a diagnosis 
symptom onset must occur before the age of 30. Furthermore common associated features 
 
include loss of touch and pain sensation, inconsistency in history and antisocial behaviour 
(DSM-IV-TR 2000). Patients with chronic health problems which include the diagnoses of 
multiple chemical sensitivity, fibromyalgia and chronic fatigue syndrome do not show these 
features and there is no evidence that psychiatric or psychological therapies alone cure the 
problems. Somatization disorder is not an appropriate diagnosis but might be used as a 
descriptive term to define the illness behaviour in which an individual communicates 
psychological distress through unexplained physical symptoms (Ford 1997; Bluui and 
Horopf 1997). It is recognized that in a wide variety of health problems  patients can 
experience some relief of suffering with appropriate psychological treatment. 
A survey of chronically ill adults in eight different countries reviewed the experiences of 
patients with chronic conditions and with complex health care needs (Schoen et al 2008). 
These authors pointed out that the goals for treatment of chronic illness are different from 
managing acute episodic illness. When health systems are designed to deal with acute 
illness the goal is usually cure rather than seeking to prevent complications and delaying 
deterioration. The major intention of any form of health care is to alleviate suffering which is 
frequently achieved in a system focusing on acute care when cure is possible. When cure is 
not possible,this becomes more difficult and suffering may increase secondary to 
inappropriate treatment or iatrogenic complications. This is well recognized in the 
management of the frail elderly in acute hospitals. It is not surprising that the study of 
Schoen and others (2008) found significant variation in care of patients with chronic illness 
in different countries. The authors conclude that there is a need to integrate care for the 
chronically ill patient around the patient, supported by information systems that provide 
timely and relevant information  and enable effective and efficient care. Integrating care 
around a patient means adopting a biopsychosocial approach to care, paying equal attention 
to biology and psychology. Patients are referred to the Nova Scotia Environmental Health 
Centre because they are ill and suffering. In the absence of any recognized effective 
approach to care we adopted the concept of person-centred patient care. In this chapter we 
review the development of this approach in the management of patients with multiple 
chemical sensitivity and offer it as a model for management of chronic disease. 
 
2. Multiple Chemical Sensitivity 
The Nova Scotia Environmental Health Centre was established in 1994 to provide care for 
environmentally sensitive patients and to conduct research into the diagnosis, pathogenesis 
and management of patients with multiple chemical sensitivity. The Department of Health 
of the province of Nova Scotia was responding to the need expressed by patients and 
physicians. Since the opening of the center the demand for clinical care has been high. 
Multiple chemical sensitivity has been identified as a disorder which is characterized by 
reactivity to environmental chemicals. Controversy exists as to the etiology and possible 
pathogenesis. Controversy continues as to whether it is a disease or an illness, and in the 
absence of identifiable structural pathology, most refer to it as an illness. If it is accepted as a 
distinct problem then what is the pathogenesis? Is it physical or psychological? This 
example of Cartesian dualism has been discussed for many years by physicians, patients 
and society at large. Since this is a poorly understood problem, many have concluded that 
this disorder is psychological and should be treated as a psychological problem. Yet there is 
little evidence that psychological or psychiatric treatment alone has helped patients 
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No such specialization has developed in dealing with younger patients with multiple 
interacting problems and it is much more difficult for primary care physicians to manage  
poorly understood chronic illnesses. Often these chronic illnesses are not recognized as 
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Sumathipala (2007) reviewed published literature for the highest level of evidence on the 
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that there was more evidence for cognitive behavioural therapy improving the health of 
these patients than for any other form of therapy. 
The term medically unexplained symptoms was probably first used by de Figueiredo (1980) 
when describing a case of Briquet’s syndrome, a recognized psychiatric disease. Since that 
introduction, the term has been used to describe any condition that lacks structural 
pathology in the tissues (Nettleton 2006; Binder 2004; Smythe 2005). It is obvious from the  
literature on medically unexplained symptoms, that many authors have a psychological or 
psychiatric background, and therefore interpret the illness as being secondary to 
psychopathology. There is little discussion of the biological aspects of the illnesses 
diagnosed in patients with unexplained medical symptoms. Another label that is applied to 
these difficult and complex patients is somatization disorder, or that the symptoms are 
manifestations of somatization. To identify the illness as somatization disorder is not 
appropriate for this patient population with chronic ill health. To make such a diagnosis 
symptom onset must occur before the age of 30. Furthermore common associated features 
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multiple chemical sensitivity, fibromyalgia and chronic fatigue syndrome do not show these 
features and there is no evidence that psychiatric or psychological therapies alone cure the 
problems. Somatization disorder is not an appropriate diagnosis but might be used as a 
descriptive term to define the illness behaviour in which an individual communicates 
psychological distress through unexplained physical symptoms (Ford 1997; Bluui and 
Horopf 1997). It is recognized that in a wide variety of health problems  patients can 
experience some relief of suffering with appropriate psychological treatment. 
A survey of chronically ill adults in eight different countries reviewed the experiences of 
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around a patient means adopting a biopsychosocial approach to care, paying equal attention 
to biology and psychology. Patients are referred to the Nova Scotia Environmental Health 
Centre because they are ill and suffering. In the absence of any recognized effective 
approach to care we adopted the concept of person-centred patient care. In this chapter we 
review the development of this approach in the management of patients with multiple 
chemical sensitivity and offer it as a model for management of chronic disease. 
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The Nova Scotia Environmental Health Centre was established in 1994 to provide care for 
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of the province of Nova Scotia was responding to the need expressed by patients and 
physicians. Since the opening of the center the demand for clinical care has been high. 
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(Davidoff & Fogarty 1994). Labelling a difficult to understand problem as a psychological 
problem is often problematical and once the Nova Scotia Environmental Health Centre was 
established in 1994 many patients were referred on their insistence that they were not 
psychologically ill, that there was “something else going on”. It soon became clear that some 
patients were extremely stressed or anxious, and some were depressed. However, because 
of their traumatic experiences with other health professionals, it was difficult at first to 
address these issues without first establishing an alliance with the patient. Any approach 
was seen as yet another physician diagnosing the illness as being “all in your head.”  
In order to be able to address psychological issues, if present, it became necessary to gain 
trust and confidence and to validate the patient’s illness experience. It was not difficult to 
recognize that the patients referred to the Nova Scotia Environmental Health Centre and 
who fulfilled the criteria for a diagnosis of Multiple Chemical Sensitivity, were ill. Indeed, it 
is generally accepted that people diagnosed with this condition are ill and experience a wide 
range of symptoms, even if there is no agreement as to whether this is a single disease. Mark 
Cullen(1987) provided a research definition of this condition, which he referred to as 
multiple chemical sensitivities. This has led to other, improved definitions, which are more 
valuable in clinical settings to establish a diagnosis (Nethercott et al 1993, Bartha et al 1999).  
The best available case definition was reached by consensus and published in 1999 (Bartha 
et al 1999). Multiple chemical sensitivity is diagnosed in a patient when the following six 
criteria are met; 
1. The symptoms are reproducible with repeated chemical exposure 
2. The condition is chronic 
3. Low levels of exposure result in manifestations of the syndrome  
4. The symptoms improve or resolve when the incitants are removed 
5. Responses occurred to multiple, chemically unrelated substances 
6. Symptoms involve multiple organ systems 
The diagnosis of Multiple Chemical Sensitivity is made when all six criteria are fulfilled and 
can be made alongside other diagnoses such as asthma, allergy, migraine, chronic fatigue 
syndrome, fibromyalgia, irritable bowel syndrome, depression, panic attacks or interstitial 
cystitis. Implicit in this consensus definition is the recognition that there is wide variability 
in the clinical presentation and in the degree of disability among patients. Disability can be 
minimal or total. The experience at the Nova Scotia Environmental Health Centre is that up 
to half our patients are disabled to the extent that they have to stop work or discontinue 
education. Symptom severity can vary from being mild to severe, including life-threatening 
anaphylaxis. Patients with multiple chemical sensitivity experience physiological 
dysfunction in various body systems manifest by the development of symptoms upon 
exposure to a triggering substance or a new environmental situation. Exposure can be by 
ingestion, inhalation or topical application to the skin. Environmentally sensitive 
individuals can experience dysfunction in more than one body system at the same time. 
Irritation of the airways can lead to rhinitis, sinusitis, cough, hoarseness, laryngeal stridor or 
asthma. Central nervous system dysfunction, present in most patients, leads to complaints 
of being unable to concentrate, to think clearly, to complete multistep tasks, to recall items 
from memory or to lay down new memories. This collection of symptoms is often referred 
to as “brain fog”. Inevitably there are mood changes in association with the symptoms, such 
as irritability, anxiety and depression. 
 
In a detailed study of 351 patients referred to the Nova Scotia Environmental Health center 
and diagnosed with multiple chemical sensitivity, it was found that 80% of the patients were 
female and 37% fell within the 40 to 49 year age group (Joffres et al 2001). The major 
symptoms experienced by this patient population were divided into two categories –  
1. Generalized symptoms such as fatigue, difficulty in concentrating, forgetfulness 
and irritability: 
2. Irritative symptoms such as sneezing, hoarseness of voice and irritated eyes. 
In the medical literature, occupational exposure has been reported to lead to the 
development of multiple chemical sensitivity, for example 13% of 160 solvent exposed 
workers (Gyntelberg et al 1986). Multiple chemical sensitivity has also developed in workers 
exposed to organophosphate pesticides(Cone and Sult 1992; Tabershaw and Cooper 1966) 
and tunnel workers exposed to gasoline contaminated soil (Davidoff et al 1998). However, 
in at least half the patients seen at NSEHC there is no identifiable toxic exposure. Although   
etiology is often unclear and pathogenesis is obscure, MCS patients who are ill share 
common features. The most obvious is the reactivity to modern environments that the 
majority of the healthy population can tolerate.  
As noted above patients who are diagnosed with multiple chemical sensitivity also have 
overlapping problems such as fibromyalgia, chronic fatigue syndrome, irritable bowel 
syndrome, interstitial cystitis, asthma, reactive upper airways dysfunction, irritant vocal 
cord dysfunction, temporomandibular disorders, myofascial pain syndrome, migraine, 
chronic pain disorder, or post-traumatic stress syndrome. These patients have often been 
categorized as having medically unexplained symptoms or somatization. Yet it is possible to 
demonstrate biological changes of physiological dysfunction. For example in the patients 
with multiple chemical sensitivity, hypersensitivity to chemicals  can be objectively 
demonstrated. This is done by exposing individuals to the presence of common household 
products without their knowledge (but with their consent and full ethical approval) and 
monitoring physiological changes (Joffres et al 2005). This is important in many patients to 
be able to obtain objective confirmation of hypersensitivity, but also because the state of 
high arousal in the nervous system can also be identified. This helps in management. There 
is evidence in the medical literature that other biological changes are found, such as 
increased nociceptive flexion reflex  in fibromyalgia (Desmeules et al 2003, Banic et al 2004), 
in chronic pain and whiplash (Banic et al 2004), and in irritable bowel syndrome (Coffin et al 
2004). There may be an absence of structural pathology, yet dysfunction can be objectively 
demonstrated. The common pathophysiological finding in these groups of patients is central 
sensitivity, and the illness is best described as Central Sensitivity Syndrome (Yunus 2000, 
2007, 2008). It is obvious that these patients who are chronically ill and disabled have a mix 
of biological changes and psychological issues. It will become clear that if this is the case 
then to alleviate suffering, physical and psychological issues need to be addressed together. 
 
3. Many challenges to health care 
It can be seen that the care of patients with multiple chemical sensitivity offers many 
challenges. Even though there is a great deal of controversy with regards to the very 
existence of this health problem, patients are identified with complex chronic ill health and 
share similar clinical features and symptoms. These patients attend the Nova Scotia 
Environmental Health Centre seeking help in understanding their health problem and for 
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challenges. Even though there is a great deal of controversy with regards to the very 
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alleviation of suffering. A continuing challenge has been the belief that the Nova Scotia 
Environmental Health Centre will offer treatments that are not available elsewhere and will 
be succesful in eradicating the problem. Many patients exhaustively search for a cure or for 
the reason that they are ill and their focus often is narrowed down to specific symptoms. It is 
a great challenge for any patient to accept the limited effectiveness of treatment for the 
various symptoms. Furthermore, that the best route to better health lies in addressing 
aspects of their health which do not seem to be immediately linked to any specific 
symptoms or single diagnosis. Closely linked to this is the challenge to accept responsibility 
for self-managment and decreasing reliance on health professionals.  
As our experience with patients referred for consultation continued, and the diversity of 
patients increased, more challenges to care became apparent. Most patients had seen a wide 
variety of health professionals yet remained symptomatic and ill. A high percentage of 
patients stated that not only were they intolerant of most modern buildings, including 
hospitals and doctors offices, but they found that any treatment offered often made them 
worse. It is extremely challenging for a physician to be faced with an ill, disabled patient 
who cannot access usual health care facilities or refuses to take a pharmaceutical that would 
normally be considered appropriate for relief of symptoms. When symptoms are found in 
multiple body systems, the level of distress in the patient increases and the challenges to the 
physician rise exponentially. This leads to more visits to a doctor’s office, to hospital or to 
the emergency room. At the time of referral to the Nova Scotia Environmental Health Centre 
the mean physician visits per patient were 2 to 3 times the average for the population of 
Nova Scotia (Fox et al 2007). Many patients had seen a number of different health 
professionals but were still seeking help, and reported increasing difficulty in finding health 
facilities that they could tolerate. Prior to the establishment of the Nova Scotia 
Environmental Health Centre it was determined that the only way to begin to understand 
the nature of this illness and to be able to help individuals was to create a facility which 
provided an environment in which environmental stress was reduced to a practical 
minimum. This has been another challenge, the need for continued vigilance in maintaining 
acceptable air quality and the financial constraints related to this. 
As more patients were seen, it became clear that the current approaches to treatment were 
unsatisfactory, and no guidelines were available which would identify which treatment was 
useful. Some treatments had been developed which were claimed to reduce environmental 
sensitivity but for which there was little supportive evidence. Sometimes treatment was 
counter-productive, not only failing to help patients get to a higher level of health, but 
aggravating symptoms. For example, treating patient as if allergic may do more harm than 
good. Patients who are extremely sensitive to modern environments that the majority of the 
population tolerates, usually state that they are allergic. However there is no evidence that 
allergic mechanisms account for the symptoms of chemically sensitive patients. This belief 
has led to the development of diagnostic and treatment methods closely related to the 
concept of allergy. This presented major challenges since treatment methods were 
controversial and research into the various approaches was essential before treatment could 
start. An example of this was the use of a form of testing for sensitivities known as 
provocation/neutralization. Some treatment options depended upon the accuracy of this 
testing and it was an expensive proposition for any patient. Early research revealed the 
difficulties with this approach and we were unable to validate the claim that chemical 
sensitivity could be accurately defined by this form of testing (Fox et al  1999). Testing 
 
provided results which were unreliable and we had to discard one of the mainstays of 
treatment and seek other approaches. 
Another challenge to appropriate treatment occurs when the illness is looked at as a purely 
physical phenomenon, for example as a result of toxic overload and psychological aspects 
ignored. Conversely, if it is concluded that the symptoms are not physical, but 
psychological, then the label of “somatization” is applied. This does not improve diagnostic 
accuracy nor help in understanding the patho-physiology. In this case focusing on the 
psychological or emotional aspects alone does nothing to relieve symptoms. An individual 
who recognizes that a scent triggers asthma or migraine is advised to avoid exposure, rather 
than to enter counseling and continue being exposed.  
Despite the many challenges, we recognized that all patients showed a varied mixture of 
problems which included evidence of structural pathology, no structural pathology but 
clear evidence of physiological dysfunction or evidence of psycho-pathology  and associated 
psychosocial issues. A major challenge in health care of these patients was to decide which 
type of physician should be providing care. Family medicine is only speciality in medicine 
which trains physicians to be prepared to manage patients of all ages, either sex and any 
kind of problem. The various constraints for primary care physicians in dealing with these 
complex problems have already been discussed. There are no other specialists available with 
appropriate training in the types of chronic illness that were being referred to the 
environmental health centre. As patient needs were identified, the team of health 
professionals expanded. However the approach retained features of the traditional medical 
model in as much as the consulting physician remained the source of entry into the various 
treatment programs at the centre. We need appropriately developed guidelines or protocols 
for care, but treatment to alleviate suffering cannot wait until all the evidence is firmly in 
place. This is a continuing challenge and care which does not harm has been developed, 
accompanied by research to evaluate the different approaches. Hopefully clear management 
guidelines may be developed in the future. 
 
4. The emergence of multidisciplinary management  
for multiple chemical sensitivity 
Programs of care, with emphasis on patient education and self-management, were 
developed, evaluated and modified as required. Initially, the rationale for education of 
patients to  reduce environmental stress, was the evidence accumulated from many patients 
that there were triggers in the environment that led to symptoms and worsening  of health. 
Furthermore, reducing environmental stress reduced symptoms and helped patients restore 
health. Physicians and nurses therefore educated patients on how to manage, and create a 
personal  environment  which was  free of identifiable triggers like fragrances, thus reducing 
the environmental stress to a practical minimum. Patients were not educated to shut 
themselves away even though many had done so for some time before being seen. All 
patients receive some basic educational material on management of their health problems. 
Since the approach to care begins with a shift towards healthy lifestyle choices and, as the 
clinic is dedicated to care of individuals with environmental senstivities, patients were 
required to change personal care products to fragrance free products If symptomatic relief 
was possible, then it was offered, obviously dictated by the nature of the problem and the 
tolerance of the individual to the different approaches. Examples of symptomatic relief 
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alleviation of suffering. A continuing challenge has been the belief that the Nova Scotia 
Environmental Health Centre will offer treatments that are not available elsewhere and will 
be succesful in eradicating the problem. Many patients exhaustively search for a cure or for 
the reason that they are ill and their focus often is narrowed down to specific symptoms. It is 
a great challenge for any patient to accept the limited effectiveness of treatment for the 
various symptoms. Furthermore, that the best route to better health lies in addressing 
aspects of their health which do not seem to be immediately linked to any specific 
symptoms or single diagnosis. Closely linked to this is the challenge to accept responsibility 
for self-managment and decreasing reliance on health professionals.  
As our experience with patients referred for consultation continued, and the diversity of 
patients increased, more challenges to care became apparent. Most patients had seen a wide 
variety of health professionals yet remained symptomatic and ill. A high percentage of 
patients stated that not only were they intolerant of most modern buildings, including 
hospitals and doctors offices, but they found that any treatment offered often made them 
worse. It is extremely challenging for a physician to be faced with an ill, disabled patient 
who cannot access usual health care facilities or refuses to take a pharmaceutical that would 
normally be considered appropriate for relief of symptoms. When symptoms are found in 
multiple body systems, the level of distress in the patient increases and the challenges to the 
physician rise exponentially. This leads to more visits to a doctor’s office, to hospital or to 
the emergency room. At the time of referral to the Nova Scotia Environmental Health Centre 
the mean physician visits per patient were 2 to 3 times the average for the population of 
Nova Scotia (Fox et al 2007). Many patients had seen a number of different health 
professionals but were still seeking help, and reported increasing difficulty in finding health 
facilities that they could tolerate. Prior to the establishment of the Nova Scotia 
Environmental Health Centre it was determined that the only way to begin to understand 
the nature of this illness and to be able to help individuals was to create a facility which 
provided an environment in which environmental stress was reduced to a practical 
minimum. This has been another challenge, the need for continued vigilance in maintaining 
acceptable air quality and the financial constraints related to this. 
As more patients were seen, it became clear that the current approaches to treatment were 
unsatisfactory, and no guidelines were available which would identify which treatment was 
useful. Some treatments had been developed which were claimed to reduce environmental 
sensitivity but for which there was little supportive evidence. Sometimes treatment was 
counter-productive, not only failing to help patients get to a higher level of health, but 
aggravating symptoms. For example, treating patient as if allergic may do more harm than 
good. Patients who are extremely sensitive to modern environments that the majority of the 
population tolerates, usually state that they are allergic. However there is no evidence that 
allergic mechanisms account for the symptoms of chemically sensitive patients. This belief 
has led to the development of diagnostic and treatment methods closely related to the 
concept of allergy. This presented major challenges since treatment methods were 
controversial and research into the various approaches was essential before treatment could 
start. An example of this was the use of a form of testing for sensitivities known as 
provocation/neutralization. Some treatment options depended upon the accuracy of this 
testing and it was an expensive proposition for any patient. Early research revealed the 
difficulties with this approach and we were unable to validate the claim that chemical 
sensitivity could be accurately defined by this form of testing (Fox et al  1999). Testing 
 
provided results which were unreliable and we had to discard one of the mainstays of 
treatment and seek other approaches. 
Another challenge to appropriate treatment occurs when the illness is looked at as a purely 
physical phenomenon, for example as a result of toxic overload and psychological aspects 
ignored. Conversely, if it is concluded that the symptoms are not physical, but 
psychological, then the label of “somatization” is applied. This does not improve diagnostic 
accuracy nor help in understanding the patho-physiology. In this case focusing on the 
psychological or emotional aspects alone does nothing to relieve symptoms. An individual 
who recognizes that a scent triggers asthma or migraine is advised to avoid exposure, rather 
than to enter counseling and continue being exposed.  
Despite the many challenges, we recognized that all patients showed a varied mixture of 
problems which included evidence of structural pathology, no structural pathology but 
clear evidence of physiological dysfunction or evidence of psycho-pathology  and associated 
psychosocial issues. A major challenge in health care of these patients was to decide which 
type of physician should be providing care. Family medicine is only speciality in medicine 
which trains physicians to be prepared to manage patients of all ages, either sex and any 
kind of problem. The various constraints for primary care physicians in dealing with these 
complex problems have already been discussed. There are no other specialists available with 
appropriate training in the types of chronic illness that were being referred to the 
environmental health centre. As patient needs were identified, the team of health 
professionals expanded. However the approach retained features of the traditional medical 
model in as much as the consulting physician remained the source of entry into the various 
treatment programs at the centre. We need appropriately developed guidelines or protocols 
for care, but treatment to alleviate suffering cannot wait until all the evidence is firmly in 
place. This is a continuing challenge and care which does not harm has been developed, 
accompanied by research to evaluate the different approaches. Hopefully clear management 
guidelines may be developed in the future. 
 
4. The emergence of multidisciplinary management  
for multiple chemical sensitivity 
Programs of care, with emphasis on patient education and self-management, were 
developed, evaluated and modified as required. Initially, the rationale for education of 
patients to  reduce environmental stress, was the evidence accumulated from many patients 
that there were triggers in the environment that led to symptoms and worsening  of health. 
Furthermore, reducing environmental stress reduced symptoms and helped patients restore 
health. Physicians and nurses therefore educated patients on how to manage, and create a 
personal  environment  which was  free of identifiable triggers like fragrances, thus reducing 
the environmental stress to a practical minimum. Patients were not educated to shut 
themselves away even though many had done so for some time before being seen. All 
patients receive some basic educational material on management of their health problems. 
Since the approach to care begins with a shift towards healthy lifestyle choices and, as the 
clinic is dedicated to care of individuals with environmental senstivities, patients were 
required to change personal care products to fragrance free products If symptomatic relief 
was possible, then it was offered, obviously dictated by the nature of the problem and the 




included the provision of medication for pain relief. However, many patients had limited 
tolerance to pharmaceuticals and in this situation, analgesia was  provided using topical 
preparations of pharmaceuticals. If a magnesium load test revealed high retention of 
administered magnesium, then parenteral magnesium was given to relieve fatigue and 
generalized muscle pains. Obviously other conditions might be identified at the time of 
initial consultation, such as celiac disease or hypothyroidism and these were treated 
appropriately. Some patients were obviously de-conditioned as a result of their illness and it 
was logical to advise exercise. During physiotherapy assessments it became clear that 
reactions identical to those triggered by the environment, could be triggered by exercise. We 
also recognized that reactions and symptoms could be triggered by emotions, even in a 
clean environment. Many patients complained of “brain fog” and so psychology was added. 
The increased patient case load and limited number of accessible personnel lead to 
development of programs in which groups could be taught skills of self management and 
ways to increase their resiliency and self-efficacy. Patients are taught practices that can be 
continued at home, or when less sensitive, in the community.Our overall approach in groups 
and for individuals was based on changing behaviour and increasing capacity to cope.  
A significant number of our patients were disabled and could not prove their illness with 
objective testing and evidence of structural pathology. A rehabilitation specialist who was 
able to coordinate the various aspects of rehabilitation was one of the first additional 
professionals to be added. Over time other professionals have been added to the health care 
team, namely dietary and occupational therapy. As mentioned, in the early days the 
physician referred the patients to the different programs as problems were identified. Some 
patients were found to be  profoundly dysfunctional with  limited tolerance for any activity. 
They required individualized therapy to help control symptoms and assist in the process of 
change or transformation. For example certain forms of psychotherapy, craniosacral 
therapy, therapeutic touch or guided imagery may shift perceptions from illness and 
despair to one of hope for improved health.  
Patients were offered programs to learn skills to manage stress, and to retrain the often 
dysfunctional autonomic nervous system. One such workshop teaches the HeartMath® tools 
such as FreezeFrame®  and Heart Lock in®  (Childre and Martin 1999). The techniques or 
tools learned in these programs are known to improve focus, creativity, and emotional 
clarity, as well as reducing stress and anxiety. They are easily learned techniques and after 
the initial workshop patients can practice and check their abilities when attending the centre 
for another appointment, by using a computer program - emWave PC. As patients monitor 
their own progress they are also learning important principles of self-management. An 
important aspect of the workshop is to present the scientific evidence that it is possible to 
reduce anxiety and to alter hormone levels (increasing DHEA and reducing cortisol) by 
regular practice of these techniques and without the necessity of additional 
pharmacotherapy (McCraty et al 1998). The HeartMath tools help in the process of change, 
and integration of mind and body. From the initial consultation, throughout all treatment 
programmes, we emphasize the importance of both mind and body, not separate but 
integrated.  
This approach is the basis of another program that has been developed, based upon the 
mindfulness based stress reduction work of Jon Kabat Zinn (Kabat-Zinn 1990. Kabat-Zinn et 
al 1992). This program runs for 10 weeks and is called the Body mind awareness program 
(BMAP) and teaches mindfulness meditation and yoga. Evaluation has shown the benefit of 
 
this approach with reduction of symptoms and improved coping skills (Sampalli et al 2009). 
Since our patient population is drawn from all the Atlantic Provinces with some patients 
coming from other parts of Canada, this program cannot be completed by these patients, 
since it requires attendance one day a week for 10 weeks. We also offer a 4 day intensive 
program to introduce patients to these techniques and practices and to encourage continued 
self-learning and practice.  
Although we may not fully understand all the contributing factors to illness in any 
individual, we can identify factors that limit health and decrease resiliency. For example, 
inability to express emotions or suppression of emotions may lead to physical symptoms 
(Abbas et al 2009) which can be helped with short term dynamic psychotherapy. If this is 
identified as an issue during the psychosocial assessment then appropriate psychotherapy is 
recommended. With improved health, reduction of symptoms and decreased disability 
return to work can be considered. If the person became ill in the workplace where there was 
significant environmental stress, such as an autobody shop or hairdressing salon, then it is 
likely that a change in employment is necessary to maintain health and prevent recurrence 
of illness. In this situation a group workshop, Prior Learning Assessment Recognition, 
which helps individuals take full stock of their accomplishments and potential, is offered to 
assist in change and prepare for work return.  
It is difficult to provide a simple prescription to move a patient from the desire for recovery 
to the pre-morbid state of health, to a willingness to explore, discover and accept a new state 
of wellness. After some initial therapy it is hoped that the patient develops the capacity to 
participate in group programs which help in continuing transformation as they learn to live 
more fully with their present condition and focus on potential rather than limitations. We 
have found that as perceptions shift, and allostatic load decreases, health improves.  
 
5. Impact of treating the whole person 
Out of necessity, the treatment approach at the Nova Scotia Environmental Health Centre 
incorporated the concept that in managing health, we cannot separate mind from body. 
Furthermore, our medical interests could not be restricted to those illnesses that only show 
clear cut and easily demonstrable structural pathology. There has always been a need to 
carefully evaluate the programs that were introduced and we have evaluated the  impact  of 
this multidisciplinary treatment approach using a symptoms questionnaires (Fox et al 2007). 
This work has shown that after the patients begin treatment at the centre, the number of 
physician visits, of all types, reduced. We looked at 563 patients who had been referred to 
the centre by physicians in the province of Nova Scotia. Each patient completed a 217 items 
symptom questionnaire of 13 body systems (Joffres et al 2001). Each patient at the NSEHC 
had a health care insurance number. This number was sent to the agency in charge of 
encryptions along with a unique identification number. The encrypted number was then 
sent to the population health research unit, Dalhousie University, which linked the 
administrative data through the encryption number and merged with basic questionnaire 
variables using the identification number. The population health research unit was 
responsible for analysis. There was no possibility to link individual data with the healthcare 
utilization information at any stage of the process, thus protecting privacy of each patient. 
Ethical approval to perform these record linkages was obtained from Dalhousie University  
Research Ethics Board. Individual patients were included in the study if they were eligible 
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included the provision of medication for pain relief. However, many patients had limited 
tolerance to pharmaceuticals and in this situation, analgesia was  provided using topical 
preparations of pharmaceuticals. If a magnesium load test revealed high retention of 
administered magnesium, then parenteral magnesium was given to relieve fatigue and 
generalized muscle pains. Obviously other conditions might be identified at the time of 
initial consultation, such as celiac disease or hypothyroidism and these were treated 
appropriately. Some patients were obviously de-conditioned as a result of their illness and it 
was logical to advise exercise. During physiotherapy assessments it became clear that 
reactions identical to those triggered by the environment, could be triggered by exercise. We 
also recognized that reactions and symptoms could be triggered by emotions, even in a 
clean environment. Many patients complained of “brain fog” and so psychology was added. 
The increased patient case load and limited number of accessible personnel lead to 
development of programs in which groups could be taught skills of self management and 
ways to increase their resiliency and self-efficacy. Patients are taught practices that can be 
continued at home, or when less sensitive, in the community.Our overall approach in groups 
and for individuals was based on changing behaviour and increasing capacity to cope.  
A significant number of our patients were disabled and could not prove their illness with 
objective testing and evidence of structural pathology. A rehabilitation specialist who was 
able to coordinate the various aspects of rehabilitation was one of the first additional 
professionals to be added. Over time other professionals have been added to the health care 
team, namely dietary and occupational therapy. As mentioned, in the early days the 
physician referred the patients to the different programs as problems were identified. Some 
patients were found to be  profoundly dysfunctional with  limited tolerance for any activity. 
They required individualized therapy to help control symptoms and assist in the process of 
change or transformation. For example certain forms of psychotherapy, craniosacral 
therapy, therapeutic touch or guided imagery may shift perceptions from illness and 
despair to one of hope for improved health.  
Patients were offered programs to learn skills to manage stress, and to retrain the often 
dysfunctional autonomic nervous system. One such workshop teaches the HeartMath® tools 
such as FreezeFrame®  and Heart Lock in®  (Childre and Martin 1999). The techniques or 
tools learned in these programs are known to improve focus, creativity, and emotional 
clarity, as well as reducing stress and anxiety. They are easily learned techniques and after 
the initial workshop patients can practice and check their abilities when attending the centre 
for another appointment, by using a computer program - emWave PC. As patients monitor 
their own progress they are also learning important principles of self-management. An 
important aspect of the workshop is to present the scientific evidence that it is possible to 
reduce anxiety and to alter hormone levels (increasing DHEA and reducing cortisol) by 
regular practice of these techniques and without the necessity of additional 
pharmacotherapy (McCraty et al 1998). The HeartMath tools help in the process of change, 
and integration of mind and body. From the initial consultation, throughout all treatment 
programmes, we emphasize the importance of both mind and body, not separate but 
integrated.  
This approach is the basis of another program that has been developed, based upon the 
mindfulness based stress reduction work of Jon Kabat Zinn (Kabat-Zinn 1990. Kabat-Zinn et 
al 1992). This program runs for 10 weeks and is called the Body mind awareness program 
(BMAP) and teaches mindfulness meditation and yoga. Evaluation has shown the benefit of 
 
this approach with reduction of symptoms and improved coping skills (Sampalli et al 2009). 
Since our patient population is drawn from all the Atlantic Provinces with some patients 
coming from other parts of Canada, this program cannot be completed by these patients, 
since it requires attendance one day a week for 10 weeks. We also offer a 4 day intensive 
program to introduce patients to these techniques and practices and to encourage continued 
self-learning and practice.  
Although we may not fully understand all the contributing factors to illness in any 
individual, we can identify factors that limit health and decrease resiliency. For example, 
inability to express emotions or suppression of emotions may lead to physical symptoms 
(Abbas et al 2009) which can be helped with short term dynamic psychotherapy. If this is 
identified as an issue during the psychosocial assessment then appropriate psychotherapy is 
recommended. With improved health, reduction of symptoms and decreased disability 
return to work can be considered. If the person became ill in the workplace where there was 
significant environmental stress, such as an autobody shop or hairdressing salon, then it is 
likely that a change in employment is necessary to maintain health and prevent recurrence 
of illness. In this situation a group workshop, Prior Learning Assessment Recognition, 
which helps individuals take full stock of their accomplishments and potential, is offered to 
assist in change and prepare for work return.  
It is difficult to provide a simple prescription to move a patient from the desire for recovery 
to the pre-morbid state of health, to a willingness to explore, discover and accept a new state 
of wellness. After some initial therapy it is hoped that the patient develops the capacity to 
participate in group programs which help in continuing transformation as they learn to live 
more fully with their present condition and focus on potential rather than limitations. We 
have found that as perceptions shift, and allostatic load decreases, health improves.  
 
5. Impact of treating the whole person 
Out of necessity, the treatment approach at the Nova Scotia Environmental Health Centre 
incorporated the concept that in managing health, we cannot separate mind from body. 
Furthermore, our medical interests could not be restricted to those illnesses that only show 
clear cut and easily demonstrable structural pathology. There has always been a need to 
carefully evaluate the programs that were introduced and we have evaluated the  impact  of 
this multidisciplinary treatment approach using a symptoms questionnaires (Fox et al 2007). 
This work has shown that after the patients begin treatment at the centre, the number of 
physician visits, of all types, reduced. We looked at 563 patients who had been referred to 
the centre by physicians in the province of Nova Scotia. Each patient completed a 217 items 
symptom questionnaire of 13 body systems (Joffres et al 2001). Each patient at the NSEHC 
had a health care insurance number. This number was sent to the agency in charge of 
encryptions along with a unique identification number. The encrypted number was then 
sent to the population health research unit, Dalhousie University, which linked the 
administrative data through the encryption number and merged with basic questionnaire 
variables using the identification number. The population health research unit was 
responsible for analysis. There was no possibility to link individual data with the healthcare 
utilization information at any stage of the process, thus protecting privacy of each patient. 
Ethical approval to perform these record linkages was obtained from Dalhousie University  




for health care coverage in the entire pre-and post-periods of study. This insured that 
patients were eligible to receive the same services in both periods. The pre-period was data 
that were extracted from one year before consultation, and the post-period was indicative of 
the information until 2002. Three cohorts of patients were studied namely 1998 1999 and 
2000 and followed until 2002. The mean physician visits in the 1998 and 1999 cohorts 
dropped close to the Nova Scotia average in the year 2000 and stayed for the next two years. 
By the time the study took place, the Nova Scotia Environmental Health Centre had been in 
existence for several years and the multidisciplinary, holistic approach to management had 
gradually developed in response to our clinical experience. Review of the number of 
physician visits before and after admission to the centre indicated that these patients with 
“untreatable illnesses” were responding to some form of treatment. At least, the number of 
physician visits was dropping. We also looked at the cost of healthcare. All 
physician/patient encounters were extracted, not just office visits. Multiple records with the 
same medical services insurance, date of service, location, and doctor were considered as a 
single visit, with the cost of the multiple records summed accordingly. Data for the Nova 
Scotia population were extracted in a similar fashion. The denominator used to calculate 
rates for the Nova Scotia population referred to the mid-year population of those eligible for 
health coverage in the province. Prevalence rates for hospital diagnoses were based on the 
primary diagnostic field only. Age for the Nova Scotia sample was calculated at the mid-
fiscal year and for the patient cohorts was calculated as age at first visit. For the 1998 cohort, 
standardized costs in the Nova Scotia Environmental Health Centre population dropped 
from $527to $328 per person (38%) between 1997 and 2002, whereas provincial averages 
increased by 19% during that same period. The 1999 cohort showed a decrease of 8% from 
$403 to $371, whereas the provincial average increased by 14%. The 2000 cohort shows the 
environmental stress(patient) group decreasing by 21% from $528 in 1999 to $418 in 2002. 
Overall, in a two-year period preceding and following active involvement in the NSEHC, 
standardized costs for physician care fell by 17%, whereas they increased by 9% in the Nova 
Scotia population. We found that there was a decrease in costs for both specialists and 
general practitioner visits, but the decrease for specialist costs was not as sharp.  
The decrease in mean physician visits was seen at all levels of symptom severity scores, and 
was more important in those with high initial scores. The symptom severity scores were 
obtained from the questionnaire. Symptom scores were calculated as the frequency of 
occurrence of symptoms since the beginning of the illness (scale 1-4; rarely, from time to 
time, most of the time, all the time) multiplied by the severity (Scale 1-3 low, moderate, 
high). Therefore the maximum score for each question was 12, and the minimum zero. A 
global score was calculated for each patient, which was the mean score computed as the 
sum of all scores divided by the number of questions. 
This study has limitations in that it was not possible to complete a full cost benefit analysis. 
Although we cannot conclude that there was a decrease in total healthcare costs our data 
certainly suggests a reduction in physician visits. 
At the time of developing the questionnaire for our patient population we completed a 
validation study to determine effectiveness and sensitivity of the questionnaire. In addition 
to the 217 symptom questions in 13 sections there were opportunities to complete open 
ended questions. Patients were asked to complete this questionnaire at the time of their 
illness and they often took 2 to 3 hours for completion. Such a lengthy questionnaire was not 
practical for repeated use in follow up, and so we identified the top 15 symptoms and used 
 
them for follow up. There are 30 questions in total in this abbreviated questionnaire, 
NSEHC-BREF, with 22 questions on symptoms and 8 questions on the overall health. The 
maximum score for each question is 12, frequency multiplied by severity. The lowest score 
possible is 0. A decrease in the score indicates improvement. SAS 9.1 was used to conduct 
this analysis of the results. 
The average time for completion of the abbreviated questionnaire is 15 minutes. Our 
intention was to use this questionnaire in an attempt to capture changes over time, which 
would be equated with better health. We approached approximately 500 patients with a 
diagnosis of multiple chemical sensitivity  (Fox et al 2008). It should be noted that many of 
these patients had other chronic conditions such as chronic fatigue syndrome or 
fibromyalgia. All patients had completed the original questionnaire, and were grouped into 
the following categories 
1. 6 month to 1 year of treatment at the Centre 
2. 1 to 2 years 
3. 2+ years treatment. 
4. Discharged 
A total of 183 patients the first three categories, still receiving treatment at  the Nova Scotia 
Environmental Health Centre were included in the study and 109 patients who had been 
discharged. Patients showed a statistically significant improvement in the overall health in 
such categories as health since ill, too ill to do housework and limited contact with people to 
avoid exposures. Some symptoms improved early on, showing statistically significant 
change within the first year such as the complaint of a stronger sense of smell or a tight 
chest. Some improvement of irritative symptoms such as nasal stuffiness and sinus 
congestion were observed in the one year and above group. Loss of voice, hoarseness and 
irritated eyes, took longer to improve showing sudden improvement in the 2+ and 
discharged groups. 
Symptoms which might be considered more generalized, such as difficulty in concentrating, 
difficulty in making decisions, tiredness not relieved by sleep, muscle spasms and cramps 
showed significant improvement in all categories of patients. Irritability, forgetfulness and 
trouble finding the right words took slightly longer but did show significant change after 
one or two years of treatment. When fatigue is identified as a problem or tiredness without 
energy, improvement was shown in the group who were discharged or who had been in 
treatment for more than two years. They were inconsistent changes in some of the other 
symptoms. 
It is challenging to measure change in chronic health conditions such as multiple chemical 
sensitivity, particularly when there are multiple diagnoses and multiple care providers. We 
know that with the passage of time, individuals change. This study helps us to identify 
whether health changes occur with time and the nature and extent of symptom changes. In 
the future it will be important to look at control populations to determine the effect of 
passage of time alone on overall health. Furthermore, we need to look more closely at the 
different aspects of our management approach to determine what is most important. 
 
6. Introduction of multidisciplinary assessment at the start of treatment 
With the passage of time it became clear that some issues were not addressed until after the 
patient had been attending the centre for some time, leaving open the possibility that if dealt 
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for health care coverage in the entire pre-and post-periods of study. This insured that 
patients were eligible to receive the same services in both periods. The pre-period was data 
that were extracted from one year before consultation, and the post-period was indicative of 
the information until 2002. Three cohorts of patients were studied namely 1998 1999 and 
2000 and followed until 2002. The mean physician visits in the 1998 and 1999 cohorts 
dropped close to the Nova Scotia average in the year 2000 and stayed for the next two years. 
By the time the study took place, the Nova Scotia Environmental Health Centre had been in 
existence for several years and the multidisciplinary, holistic approach to management had 
gradually developed in response to our clinical experience. Review of the number of 
physician visits before and after admission to the centre indicated that these patients with 
“untreatable illnesses” were responding to some form of treatment. At least, the number of 
physician visits was dropping. We also looked at the cost of healthcare. All 
physician/patient encounters were extracted, not just office visits. Multiple records with the 
same medical services insurance, date of service, location, and doctor were considered as a 
single visit, with the cost of the multiple records summed accordingly. Data for the Nova 
Scotia population were extracted in a similar fashion. The denominator used to calculate 
rates for the Nova Scotia population referred to the mid-year population of those eligible for 
health coverage in the province. Prevalence rates for hospital diagnoses were based on the 
primary diagnostic field only. Age for the Nova Scotia sample was calculated at the mid-
fiscal year and for the patient cohorts was calculated as age at first visit. For the 1998 cohort, 
standardized costs in the Nova Scotia Environmental Health Centre population dropped 
from $527to $328 per person (38%) between 1997 and 2002, whereas provincial averages 
increased by 19% during that same period. The 1999 cohort showed a decrease of 8% from 
$403 to $371, whereas the provincial average increased by 14%. The 2000 cohort shows the 
environmental stress(patient) group decreasing by 21% from $528 in 1999 to $418 in 2002. 
Overall, in a two-year period preceding and following active involvement in the NSEHC, 
standardized costs for physician care fell by 17%, whereas they increased by 9% in the Nova 
Scotia population. We found that there was a decrease in costs for both specialists and 
general practitioner visits, but the decrease for specialist costs was not as sharp.  
The decrease in mean physician visits was seen at all levels of symptom severity scores, and 
was more important in those with high initial scores. The symptom severity scores were 
obtained from the questionnaire. Symptom scores were calculated as the frequency of 
occurrence of symptoms since the beginning of the illness (scale 1-4; rarely, from time to 
time, most of the time, all the time) multiplied by the severity (Scale 1-3 low, moderate, 
high). Therefore the maximum score for each question was 12, and the minimum zero. A 
global score was calculated for each patient, which was the mean score computed as the 
sum of all scores divided by the number of questions. 
This study has limitations in that it was not possible to complete a full cost benefit analysis. 
Although we cannot conclude that there was a decrease in total healthcare costs our data 
certainly suggests a reduction in physician visits. 
At the time of developing the questionnaire for our patient population we completed a 
validation study to determine effectiveness and sensitivity of the questionnaire. In addition 
to the 217 symptom questions in 13 sections there were opportunities to complete open 
ended questions. Patients were asked to complete this questionnaire at the time of their 
illness and they often took 2 to 3 hours for completion. Such a lengthy questionnaire was not 
practical for repeated use in follow up, and so we identified the top 15 symptoms and used 
 
them for follow up. There are 30 questions in total in this abbreviated questionnaire, 
NSEHC-BREF, with 22 questions on symptoms and 8 questions on the overall health. The 
maximum score for each question is 12, frequency multiplied by severity. The lowest score 
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diagnosis of multiple chemical sensitivity  (Fox et al 2008). It should be noted that many of 
these patients had other chronic conditions such as chronic fatigue syndrome or 
fibromyalgia. All patients had completed the original questionnaire, and were grouped into 
the following categories 
1. 6 month to 1 year of treatment at the Centre 
2. 1 to 2 years 
3. 2+ years treatment. 
4. Discharged 
A total of 183 patients the first three categories, still receiving treatment at  the Nova Scotia 
Environmental Health Centre were included in the study and 109 patients who had been 
discharged. Patients showed a statistically significant improvement in the overall health in 
such categories as health since ill, too ill to do housework and limited contact with people to 
avoid exposures. Some symptoms improved early on, showing statistically significant 
change within the first year such as the complaint of a stronger sense of smell or a tight 
chest. Some improvement of irritative symptoms such as nasal stuffiness and sinus 
congestion were observed in the one year and above group. Loss of voice, hoarseness and 
irritated eyes, took longer to improve showing sudden improvement in the 2+ and 
discharged groups. 
Symptoms which might be considered more generalized, such as difficulty in concentrating, 
difficulty in making decisions, tiredness not relieved by sleep, muscle spasms and cramps 
showed significant improvement in all categories of patients. Irritability, forgetfulness and 
trouble finding the right words took slightly longer but did show significant change after 
one or two years of treatment. When fatigue is identified as a problem or tiredness without 
energy, improvement was shown in the group who were discharged or who had been in 
treatment for more than two years. They were inconsistent changes in some of the other 
symptoms. 
It is challenging to measure change in chronic health conditions such as multiple chemical 
sensitivity, particularly when there are multiple diagnoses and multiple care providers. We 
know that with the passage of time, individuals change. This study helps us to identify 
whether health changes occur with time and the nature and extent of symptom changes. In 
the future it will be important to look at control populations to determine the effect of 
passage of time alone on overall health. Furthermore, we need to look more closely at the 
different aspects of our management approach to determine what is most important. 
 
6. Introduction of multidisciplinary assessment at the start of treatment 
With the passage of time it became clear that some issues were not addressed until after the 




with earlier, improvement would have started earlier. Furthermore, if the initial focus of 
treatment was only on physical issues at first, we wondered if this contributed to the 
reluctance of some patients to consider the impact of emotion on physical problems and 
delay or exclude the possibility of psychological help. It was decided that all patients should 
be assessed by all professional disciplines at the beginning of their care so that the various 
issues could be identified and if appropriate, managed early on in the course of treatment. 
All patients then recognized that we were completing careful assessments, psychological 
and physical, and were less likely to be reluctant. Over 4 years ago we began a series of 
planning meetings to find the best way of incorporating multidisciplinary assessment at the 
commencement of care for all new patients of the Nova Scotia Environmental Health Centre. 
The outcome of these planning meetings was the introduction of the multidisciplinary 
assessment following the initial consultation by a physician at the centre. The revised care 
management scheme is outlined in the following paragraph. Figure 1 shows a schematic of 
the Nova Scotia Environmental Health Centre care model for complex and chronic 
conditions. The initial consultation lasts for one and a half hours and much information is 
gathered. The physician develops a problem list and identifies the various diagnoses that 
can be made. Recommendations are made which include whether the patient should return 
to the centre for a multidisciplinary assessment. This decision is not based upon a particular 
diagnosis, but rather on whether the patient has a chronic illness and clinical features which 
support the presence of central sensitivity (Yunus 2008). Most patients seen have a diagnosis 
of multiple chemical sensitivity often in association with fibromyalgia or chronic fatigue 
syndrome. Some patients have evidence of some new sensitivities but the major problem is 
not multiple chemical sensitivity rather fibromyalgia or chronic fatigue syndrome. There are 
an increasing number of patients who are ill, often enough to be disabled from work, where 
the question is asked if their illness is related to the environment, and who do not fulfill the 
consensus criteria for multiple chemical sensitivity, chronic fatigue syndrome or 
fibromyalgia. Such a person is referred for multidisciplinary assessment since it is clear that 
they are disabled and we conclude that they may well benefit from this approach to 
management.  
At the time of the initial interview the patient has completed the detailed 217 item 
questionnaire, and is then asked to complete a one week dietary record and a two week 
record of activity (measured by a pedometer) in which they also record sleep pattern, pain 
level and fatigue level. They return for a morning in which they are seen by the various 
health professionals – nurse, dietician, psychologist or psychotherapist, coordinator of 
rehabilitation and occupational therapist (initially the team included a physiotherapist). The 
team meets together to discuss findings, interpretations and recommendations for treatment 
following completion of the assessments. A set of recommendations are agreed upon and 
the physician then meets with the patient to discuss further treatment. During this interview 
recommendations may change as the availability of the patient and other circumstances 
become clear.  
The treatment plan depends upon the patient’s willingness to learn self-management and to 
make necessary changes to restore health. Even though most patients are ill enough to seek 
medical help, and about half are so disabled that they have to stop work, it may take some 
time for an individual to accept that they have a significant illness and that they need to 
change. Old habits are hard to break and for some patients unhealthy life style habits such 
as smoking or heavy alcohol consumption need to be addressed at the outset. When there 
 
are other clear stressors such as a poor diet or excessive consumption of cola drinks or 
caffeine containing beverages this is often the focus, and the dietician plays a major role in 
care early on. Patients may also require guidance on pacing their activities, this is apparent 
from the records which each patient has completed. Other recommendations depend upon 
the most prominent features.  
 
 Fig. 1. Schematic of the Nova Scotia Environmental Health Centre Model of Care 
 
If the patient is disabled and unable to work then proof of disability is often the highest 
priority. This can be most challenging when objective findings are not present. In this 
situation initial management at the Nova Scotia Environmental Health Centre may be in 
confirming the presence of environmental sensitivity by objective testing (Joffres et al 2005) 
and providing evidence of impaired functional capacity – if possible with a formal 
functional capacity evaluation by a professional familiar with this type of health problem.  
Once the treatment plan is developed and the individual problems are addressed we are left 
with ill, disabled patients who are prepared to make changes to gain better health and 
return to work. Since our goal is to alleviate suffering we have created an environment to 
favour self-healing. We seek to foster salutogenesis (the creation of health) and decrease the 
impact of pathogenesis (the creation of suffering or disease). The salutogenic theory was 
proposed by Anton Antonovsky (1979). Antonovsky proposed that in managing chronic 
disease the emphasis should be to encourage movement towards health, and that a major 
consideration in health promotion needs to be enhancement of what he refers to as a sense 
of coherence(Antonovsky 1996). Our approach initially developed as we learned that many 
factors contributed to the illnesses that our patients experienced and if we were to alleviate 
suffering we needed to address these various aspects. As we have learned more of the 
nature of these illnesses the rationale or scientific underpinning of our approach has been 
validated. 
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7. Results of multidisciplinary assessment 
By emphasizing the integration of mind and body and by introducing psychosocial 
assessment at the same time as detailed physical/biological assessments, we are able to 
focus our therapeutic efforts in the most appropriate area. All patients need help in reducing 
contaminants – whether from the outer (environmental stress) or inner (emotional) 
environments. The balance of emphasis varies between patients and this can be determined 
early on in the course of management.  
At the time of introducing multidisciplinary assessments for all patients who were to receive 
treatment at the centre, we decided to follow progress in a variety of ways. Each program is 
evaluated through research   to measure treatment efficacy. In addition, each patient 
completed the 217 item questionnaire at the time of initial consultation. Each patient also 
completed the NSEHC-BREF questionnaire (Fox et al 2008) after 6 months of treatment, after 
1 year and after 2 years. The same patients have been followed throughout . In this section, 
the results from a group of 250 patients who went through the multidisciplinary 





          6m-1yr (n=250) 
Pre      Post    p-value 
Mean  Mean        
(SD)     (SD) 
 
            1 – 2 yr (n=153) 
Pre        Post     p-value 
Mean    Mean       
(SD)      (SD) 
 
           2+ yr (n=65) 
Pre       Post     p-value 
Mean   Mean        







3.52     4.22      0.05 
(1.2)    (1.5) 
 
3.64        5.35     <0.0001 
(1.2)       (1.4) 
 
3.45        5.4    <0.0001 









2.75     1.82       0.02 
 
(1.1)    (1.2) 
 
2.88       1.7        0.01 
 
(1.1)      (1.2) 
 
2.72         1.9     0.02 
 
(1.1)       (0.9) 
 




3.6       3.1         0.05 
(0.8)   (1.2) 
 
3.45        2.8        0.001 
(0.8)      (1.01) 
 
3.82          2.5     0.002 
(1.02)      (1.1) 
 
Table 1. Changes measured in overall health in patients who received multi-disciplinary 
assessments at commencement of treatment  
 
Since the original study using the NSEHC-BREF the major change that has occurred has 
been the introduction of the multidisciplinary assessment. The population of patients is 
similar and the main programs of treatment have remained the same. The results before and 
after introduction of the multidisciplinary process have been compared. 
 
 
Period of time in 
follow up 
6 mth – 1 yr 
Pre-        Post 
1 -2 years 
Pre-        Post 
More than 2 years 








2.75         1.82  2.88        1.7 2.72        1.9 
Table 2. Pre- and Post-introduction of Multidisciplinary assessment – Question 2. Limit 
contact with other people to avoid exposure 
 
Two hundred and fifty patients have completed the NSEHC-BREF questionnaire between 6 
and 1 year, 153 have completed the questionnaire between 1 and 2 years and 65 have now 
gone beyond 2 years. The length of treatment and the specific type of therapy varies but the 
results are of great interest. 
In the first study (pre-assessments), the patients were different in each group and this is 
reflected in the variation in the initial score, prior to treatment as  shown in Table 2. There 
was no significant change after treatment at 6 months or 1 year. Only at 2 years did the 
change reach statistical significance (p-value 0.02). In the post-multidsiciplinary assessment  
set of results, the changes across time periods are captured in the same group of patients. 
The variation in the pre scores is due to the changes in the sample size at the three time 
periods. In contrast to the pre-assessment results, the reduction of this symptom was 
statistically significant for each of the 3 time periods. This is a significant  difference in this 
patient population which demonstrates that chemically sensitive patients learned faster  to 
cope with being sensitive and did not perceive the same need to limit contact with others to 
reduce chemical exposures. It would appear that from the outset, the patients experience 
some gains in health that changes their behaviour. This needs further exploration.  
Looking at the 8 questions pertaining to irritative symptoms in the eyes and respiratory 
system, the changes are comparable between the two studies. The results for the patients 
seen after the introduction of assessments are shown in Table 3. In the 2 year group, there 
were only 65 patients and for the symptoms of burning eyes there was no improvement 
seen. In the previous study, (Fox et al 2008) there were 118 patients in this group and this 
symptom had improved at 2 years (p value 0.05). The improvement in question 2 was 
similar and reached significance at 2 years (p-value <0.0001) for the pre-assessment patients. 
It can be seen in Table 3 that this symptom showed significant improvement in all of the 
post-assessment groups. All other questions were comparable, showing similar changes in 
the same time periods.  
In the post-assessment group, all  of the questions which asked about more generalized 
symptoms – namely difficulty in concentrating, forgetfulness or poor memory, feeling light 
headed, irritability, tiredness not relieved by sleep, fatigue or very tired without energy and 
muscle pain or ache not related to exercise  showed significant improvement in the first 
cohort between 6 months and 1 year (Table 4). In contrast, the follow up study prior to the 
introduction of the assessment process did not show the same degree of improvement. 
There was no significant change in the first time period (6 months to 1 year) in four of the 
questions in this cohort – namely forgetfulness; irritability; fatigue or very tired without 
energy; and muscle pain, ache without exercise. 
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Question           6m-1yr (n=250) 
Pre      Post     p-value 
Mean  Mean        
(SD)    (SD) 
 
            1 – 2 yr (n=153) 
Pre      Post    p-value 
Mean   Mean       
(SD)     (SD) 
 
           2+ yr (n=65) 
Pre     Post    p-value 
Mean  Mean        




2.8        2.7       0.7 
(2.1)     (2.2) 
 
3.1        2.9         0.4 
(2.7)    (2.5) 
 
3            2.6      0.07 
(3.2)     (2.5) 
 
Itchy eyes 2.15     1.22      0.0008 
(2.4)    (1.5) 
3.2       2.33       0.0009 
(3.8)     (2.3) 
 
2.5        1.01    <0.0001 




5.2       4.7        0.9 
(4.9)    (3.5) 
5.1        3.3        0.008 
(4.9)     (3.7) 
 
5.4        2.8      <0.0001 





3.95     2.35     0.08 
(3.3)    (2.5) 
 
4.2        2.2         0.02 
(3.8)    (1.9) 
 
3.5       1.6        0.03 







4.8       4.4       0.4 
(3.5)    (3.6) 
 
5.2        4.5        0.09 
(4.6)     (3.7) 
 
4.9       3.1        0.01 
(4.1)    (3.5) 
 
Tight chest 2.6       1.1       0.01 
(1.9)   (1.8) 
3.5        1.3         0.0006 
(3.1)     (1.7) 
 
2.5       1.5        <0.0001 




2.7       2.2        0.5 
(1.9)    (1.3) 
 
3.2        2.6         0.5 
(2.4)    (3.2) 
 
2.9       1.3        <0.0001 
(3.5)   (1.1) 
 
Table 3. Changes in symptoms in eyes, nose, throat and respiratory systems 
 
8. Emergence of interdisciplinary care 
As the various health professionals have worked together in an increasingly integrated 
fashion it has become clear that timely and relevant collaborative care management is 
important to deliver seamless care for individuals with complex health conditions such as 
multiple chemical sensitivity. The consistent themes of self-management and self awareness 
or mindfulness are introduced early on in the care. The core principles of support and 
education for a patient reinforced by all health professionals include raising awareness of 
one’s  capacity, pacing of activities, healthy lifestyle choices and maintaining a balance 
between avoidance of situations that trigger symptoms and engaging in life which 
inevitably brings environmental and other stresses . We reinforce the need to be aware of 
body signals and introduce techniques to reduce high levels of arousal in the nervous 
system. Members of the health care team try to model this balance in their treatment 
strategies to  encourage reduced arousal. Different health professionals work together to 
deliver educational programs and workshops, for example mindfulness is the basis for a 
nutritional workshop entitled “Mindful eating”. We meet regularly to ensure that our 
 
approaches support one another and more importantly assist the patient in moving towards 
health. We foster an environment of trust and of  hope but at the same time of recognizing 
what our limitations are and that not all illnesses and disease can be fully alleviated. If 
disability persists, then it needs to be accepted. It is still possible to move along the 
continuum between health and disease, towards health – particularly as concepts of what it 
means to be healthy shift. In this way the management has become interdisciplinary. 
 
Table 4. Changes measured in blood/gland, muscle, joints and nervous system 
 
 
Period of time 
follow up 
   6m-1yr (n=250) 
Pre   Post   p-value 
Mean  Mean 
(SD)    (SD) 
   1 – 2 yr (n=153) 
Pre   Post  p-value 
Mean Mean 
(SD)   (SD) 
   2+ yr (n=65) 
Pre  Post   p-value 
Mean Mean 
(SD)   (SD) 
Difficulty 
concentrating 
5.0      3.1       0.01 
(4.9)   (2.5) 
 
5.8      2.8     0.0002 
(4.6)    (2.4) 
6.2       2.9      <0.0001 





3.2      1.7       0.004 
(2.8)   (1.5) 
 
4.6      2.1     0.0009 
(3.3)    (2.5) 
4.9       1.2       <0.0001 
(4.1)    (1.4) 
Feeling light 
headed 
4.4      2.3        0.05 
(3.3)   (2.1) 
 
4.8      2.1      0.009 
(3.9)   (2.8) 
 
5.9        2.5      <0.0001 
(5.7)    (2.1) 
Irritability 3.2      1.3        0.07 
(3.1)   (2.6) 
 
3.5      1.4       0.04 
(2.4)   (1.3) 
 
3.8       1.2       <0.0001 




7.2      4.5        0.004 
(4.8)   (3.1) 
 
7.9      4.9       0.003 
(5.2)   (2.5) 
 
6.5       2.9         0.0001 




5.9       3.2      0.0001 
(3.1)    (1.9) 
5.4     2.1      0.0002 
(3.5)   (1.8) 
6.2       1.3       <0.0001 
(5.4)    (1.1) 
Muscle pain or 
ache not 
related to over 
exercise 
4.8       2.9       0.03 
(2.9)    (1.4) 
 
4.5      2.1       0.004 
(2.6)   (1.4) 
 
4.1       3.7         0.2 
(3.5)   (1.1) 
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education for a patient reinforced by all health professionals include raising awareness of 
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body signals and introduce techniques to reduce high levels of arousal in the nervous 
system. Members of the health care team try to model this balance in their treatment 
strategies to  encourage reduced arousal. Different health professionals work together to 
deliver educational programs and workshops, for example mindfulness is the basis for a 
nutritional workshop entitled “Mindful eating”. We meet regularly to ensure that our 
 
approaches support one another and more importantly assist the patient in moving towards 
health. We foster an environment of trust and of  hope but at the same time of recognizing 
what our limitations are and that not all illnesses and disease can be fully alleviated. If 
disability persists, then it needs to be accepted. It is still possible to move along the 
continuum between health and disease, towards health – particularly as concepts of what it 
means to be healthy shift. In this way the management has become interdisciplinary. 
 
Table 4. Changes measured in blood/gland, muscle, joints and nervous system 
 
 
Period of time 
follow up 
   6m-1yr (n=250) 
Pre   Post   p-value 
Mean  Mean 
(SD)    (SD) 
   1 – 2 yr (n=153) 
Pre   Post  p-value 
Mean Mean 
(SD)   (SD) 
   2+ yr (n=65) 
Pre  Post   p-value 
Mean Mean 
(SD)   (SD) 
Difficulty 
concentrating 
5.0      3.1       0.01 
(4.9)   (2.5) 
 
5.8      2.8     0.0002 
(4.6)    (2.4) 
6.2       2.9      <0.0001 
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(2.8)   (1.5) 
 
4.6      2.1     0.0009 
(3.3)    (2.5) 
4.9       1.2       <0.0001 
(4.1)    (1.4) 
Feeling light 
headed 
4.4      2.3        0.05 
(3.3)   (2.1) 
 
4.8      2.1      0.009 
(3.9)   (2.8) 
 
5.9        2.5      <0.0001 
(5.7)    (2.1) 
Irritability 3.2      1.3        0.07 
(3.1)   (2.6) 
 
3.5      1.4       0.04 
(2.4)   (1.3) 
 
3.8       1.2       <0.0001 




7.2      4.5        0.004 
(4.8)   (3.1) 
 
7.9      4.9       0.003 
(5.2)   (2.5) 
 
6.5       2.9         0.0001 




5.9       3.2      0.0001 
(3.1)    (1.9) 
5.4     2.1      0.0002 
(3.5)   (1.8) 
6.2       1.3       <0.0001 
(5.4)    (1.1) 
Muscle pain or 
ache not 
related to over 
exercise 
4.8       2.9       0.03 
(2.9)    (1.4) 
 
4.5      2.1       0.004 
(2.6)   (1.4) 
 
4.1       3.7         0.2 





 Fig. 2. Integrating care for complex conditions 
 
In working together as a team, each individual brings their unique skills and perspectives to 
focus on particular problems and treat different aspects. The focus of each clinican may be 
upon one particular symptom at one time. At the same time, the collective focus needs to be 
on improved quality of life for the patient, through better function. The need to maintain 
this goal of increased  coherence towards salutogenesis has become more apparent with 
time and will be part of our continued development as a team. The principles are 
represented schematically in Figure 2. 
The adoption of a patient –centred approach to management is consistent with the evidence 
that already exists in the medical literature that there is great variability between 
patients.Various subgroups have been identified in patients diagnosed with fibromyalgia 
(Turk et al 1998, Giesecke et al 2003, Harris et al 2005) and treatment outcomes vary between 
the different sub-groups (Turk et al 1998). 
The various conditions that are seen at Nova Scotia Environmental Health Centre share a 
common characteristic and that is central sensitivity (Yunus 2008). Central sensitivity has 
 
been objectively confirmed in fibromyalgia, irritable bowel syndrome and temporo-
mandibular problems. Our clinical experience allows us to postulate that the same 
phenomenon exists in patients with multiple chemical sensitivity. The physiology of central 
sensitivity is activation of nociceptors of the A-delta and C fibers at the peripheral tissues by 
bradykinin, serotonin, prostaglandins and substance P. This follows inflammation that may be 
caused by even minor trauma. A variety of changes cause an escalation of hyperexcitability of 
second-order neurons, giving rise to hypersensitivity to various peripheral stimuli. When pain 
results it can be enhanced by emotion and selective attention. It is clear that other factors are 
likely to affect central sensitvityy namely genetics, sympathetic overactivity, endocrine 
dysfunction, viral infection, peripheral nociceptor generators like arthritis, poor sleep, 
environmental stimuli like weather, noise and chemicals, trauma and psychosocial distress. It 
is hoped that with time we will gain a better understanding of these issues and move further 
upstream to prevent descent into ill health. Our approach which developed over several years 
addresses these various issues. We have shown that improvement in an individual’s ability to 
manage their own health problems accompanies reduction of symptoms. Clearly the earlier 
that each person can learn what is important in fostering health, the more likely it is that health 
is maintained and disability reduced. 
Many of our quality and research intiatives are aimed at improving the collaborative 
environment among multidisciplinary clinicians that are involved in the care management 
of patients. These initiatives include revision of the Centre’s care model, standardizing 
clinical assessements and exploring semantic interoperability to the multidisciplinary 
clinical vocabulary (Sampalli et al 2010). The Centre’s revision of the care model shown in 
figure 2, is geared towards shifting the focus of the care team into a layer of modelling a 
patient’s health above the level of symptom management. In the new model, the functioning 
of the care team will be integrated around  more meaningful outcomes such as coherence, 
quality of life and function. The primary objective of this shift is to center the care team’s 
efforts towards the salutogenic approach of enabling self-efficacy and coherence in patients. 
The Centre’s efforts will also continue towards standardizing clinical vocabulary and 
assessment tools used by the multidisciplinary clinicians in order to facilitate a higher level 
of shared understanding and coherence in the collaborative functioning of  clinicians. 
 
9. Conclusion 
The limited treatment options and the inability for most patients to find any kind of effective 
medical treatment lead to the establishment of the Nova Scotia Environmental Health 
Centre. The multidisciplinary approach grew out of the recognition of the complex 
interactions that span multiple health dimensions and appear to govern the well-being of 
individuals with this illness; and the ineffectiveness of uni-dimensional treatment models in 
addressing the multitude of symptoms. It soon became clear that improving health of both 
body and mind alleviated suffering and reduced disability.  
The care model for a complex chronic illness discussed in this chapter focuses on multiple 
chemical sensitivity. The findings reported here are undoubtedly relevant to other complex, 
chronic illnesses of uncertain etiology when there is often limited understanding of 
pathogenesis. We have shown that poorly understood chronic medical conditions which 
result in significant health care costs and disability can be helped by an interdisciplinary 
approach which focuses on movement to health – salutogenesis rather than pathogenesis.  
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